Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Free Cash Flow (2024 - 2025)

Historic Free Cash Flow for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to -$25.6 million.

  • Kestra Medical Technologies' Free Cash Flow fell 1379.82% to -$25.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$113.6 million, marking a year-over-year decrease of 7180.01%. This contributed to the annual value of -$100.5 million for FY2025, which is 1904.19% down from last year.
  • Per Kestra Medical Technologies' latest filing, its Free Cash Flow stood at -$25.6 million for Q4 2025, which was down 1379.82% from -$34.4 million recorded in Q3 2025.
  • Kestra Medical Technologies' 5-year Free Cash Flow high stood at -$19.1 million for Q2 2024, and its period low was -$34.4 million during Q3 2025.